Ideas For Now-

Discussion in 'Stocks' started by stonedinvestor, Apr 27, 2020.

  1. Van it looks like FLDM is your play-! It's up 10% with lots more room to run. T-$22.
    Fluidigm Corporation (FLDM)

    8.54+0.02 (+0.23%)
    At close: October 7 4:00PM EDT
    9.41 +0.87 (10.19%)<---------
    Before hours: 9:12AM EDT
     
    #1671     Oct 8, 2020
  2. You let Bees in the greenhouse.
     
    #1672     Oct 8, 2020
  3. vanzandt

    vanzandt

    They fly around when its cold out? What if you live in Alaska?
     
    #1673     Oct 8, 2020
  4. Nope sorry it's VERI. <-- That's the one I would ride.

    Bit rusty this am lot on my mind I have to call the prior owner of my house in Ct he happens to be a lawyer so I'm scared. I'm hoping he has the original documents and legacy paragraphs etc. I want to invite him over for sat I could show him what's going on... but then if he doesn't show up I'll feel stupid. It's last bullet time. The last possible attempt at saving the Grotto.
     
    #1674     Oct 8, 2020
  5. If you live in Alaska you're not eating a lot of fruit anyway.
     
    #1675     Oct 8, 2020
  6. So Trumps REGN cocktail would cost the average American over $100,000.
    Think Insurance will pick that up.
    Trump wants to make it free. Yea right. $100,000 X 2 mil

    This is dangerous what this guy is doing very dangerous. The average American will not get the REGN product. But they may race ahead and get sick.
     
    #1676     Oct 8, 2020
  7. DAVIDsTEA Inc. (DTEA)

    $1.2100+0.0400 (+3.42%)
     
    #1677     Oct 8, 2020
  8. Friday) ) ) ) ) )

    There's a beautiful irony today to learn that aborted baby fetuses were floating around the President's blood stream. Egads, not him too! Wait till the Qeonon people realize their leader is a walking aborted fetus. Oh it's so creature of the White Lagoon isn't it? Life's beautiful ironies... the only thing better would be a complete blood transfusion from a Black man from a poor country.

    MOVIE THEATERS ARE TOAST VAN!!!! Anoher huge blos--or is it????/
    Disney moves 'Soul' to streaming, in theaters' latest loss
    Oct. 8, 2020 6:29 PM ET|About: The Walt Disney Company (DIS)|

    Chalk up another big-budget theatrical casualty: Disney (NYSE:DIS) is moving its planned in-theater release of Pixar film Soul to Disney Plus exclusively on Christmas Day.

    Unlike the plan with Mulan - the tentpole film Disney moved to the streaming service for a $29.99 "Premier Access" add-on price - Soul will simply be free to Disney Plus subscribers.<---

    Yea Disney massively screwed up with their last release trying to gouge people for an additional $30 ontop pf their Disney + fee... That flopped.

    In international markets where Disney Plus isn't currently or soon to be available, Soul will get a theatrical release.

    It had been planned for a November release, and recent postponements left it as the highest-profile major-studio release between now and December.<-----
     
    #1678     Oct 9, 2020
  9. GameStop +21% after Microsoft development
    Oct. 8, 2020 3:12 PM ET|About: GameStop Corp. (GME)|By: Clark Schultz, SA News Editor
    GameStop (NYSE:GME) jumps 21.15% after trading is resumed following an exchange halt.

    Investors are bidding up the stock after the announcement of an enterprise and commercial partnership with Microsoft.

    That announcement arrived with short interest on GameStop at more than 100% of total float.

    Shares of GameStop have traded as high as $11.90 this afternoon. [​IMG]
     
    #1679     Oct 9, 2020
  10. What do you do when you have a great story stock and no one cares? My experience has been that if you really did a lot of research you should stick it out. However this can become a ten year process. And who really has time for that?

    Enter Kamada. It's been one of my top 3most frustrating stocks... It should of rallied on the Trump REGN cocktail news. It didn't. It acted like a stock that has shorts at it... I don't know...
    it would be easy to cut and run but then you read a blurb on the Bloomblurb and it says...

    Takeda, others testing convalescent plasma treatment in Covid, WSJ reports <-----------
    and you say to yourself Takeda why does that ring a bell-?

    7 Oct. 2020
    Kamada Provides Update on 2021 GLASSIA® Supply to Takeda
    • Kamada Expects to Receive $25 Million in Revenues from Sales of GLASSIA® to Takeda in 2021 which is Takeda’s Minimum Commitment for 2021 Pursuant to the Existing Supply Agreement
     
    #1680     Oct 9, 2020